{"nct_id":"NCT03418532","title":"MP0250 DARPin® Protein Plus Osimertinib in Patients With EGFR-mutated NSCLC","status":"TERMINATED","status_verified_date":"2023-03","start_date":"2018-03-22","start_date_type":"ACTUAL","primary_completion_date":"2019-08-30","primary_completion_date_type":"ACTUAL","completion_date":"2020-04-24","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["MOLN"]}